Cardiovascular endocrinology has entered a period of rapid expansion, driven by advances in molecular profiling, translational therapeutics, and integrative ...

(Kobe University) Palm reading may not foresee your future, but if you flip your hand around, it could reveal crucial information about how long you may live. According to new research, a simple photo ...

What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...

A study from the University of Limerick in Ireland has identified the hidden challenges of women living with and managing Gestational Diabetes Mellitus (GDM). The research led by academics in UL's ...

Multiple randomized clinical trials now show that type 2 diabetes can be pushed into remission through structured weight loss ...

Rising NEC Incidence: The global increase in diagnosed cases of neuroendocrine tumors (including carcinomas) is a major market growth driver. This uptick is driven by better detection and reporting, ...

HighlightsPotash mineralization confirmed at two historical drillholes on flagship Disley Project, including 6.1m grading 41.3% sylvite (KCl);The first two of three assay results as part of Buffalo's ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Hims & Hers Benefits, a new way for subscribers to access the best innovations in whole body health.

In studies published so far, GLP-1 receptor agonists appear to be beneficial for the treatment of glaucoma, according to a review published in Cureus. Daily intake of avocado and mango may improve ...

Obesity research has become increasingly relevant as global rates of overweight and obesity continue to rise, affecting all age groups and communities.

SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology company, today unveiled the Path Fertility Facts Sheet, a copy of which is embedded ...

Here are five key takeaways for regarding the use of GLP-1 receptor agonists in patients who are undergoing breast cancer ...